Gemigliptin, a novel dipeptidyl peptidase-IV inhibitor, exerts a synergistic cytotoxicity with the histone deacetylase inhibitor PXD101 in thyroid carcinoma cells.
about
Gemigliptin, a novel dipeptidyl peptidase-IV inhibitor, exerts a synergistic cytotoxicity with the histone deacetylase inhibitor PXD101 in thyroid carcinoma cells.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Gemigliptin, a novel dipeptidy ...... 01 in thyroid carcinoma cells.
@en
Gemigliptin, a novel dipeptidy ...... 01 in thyroid carcinoma cells.
@nl
type
label
Gemigliptin, a novel dipeptidy ...... 01 in thyroid carcinoma cells.
@en
Gemigliptin, a novel dipeptidy ...... 01 in thyroid carcinoma cells.
@nl
prefLabel
Gemigliptin, a novel dipeptidy ...... 01 in thyroid carcinoma cells.
@en
Gemigliptin, a novel dipeptidy ...... 01 in thyroid carcinoma cells.
@nl
P2093
P2860
P1476
Gemigliptin, a novel dipeptidy ...... 01 in thyroid carcinoma cells.
@en
P2093
P2860
P2888
P356
10.1007/S40618-017-0792-X
P577
2017-11-16T00:00:00Z